Bär & Karrer had the pleasure of contributing to the third edition of Life Sciences – Switzerland in the Legal Industry Reviews with a chapter on Cost Containment Measures in Switzerland Regarding Pharmaceuticals: Pricing Models Under Current and New Law and their impact on pharmaceutical pricing in Switzerland. Written by Prof. Dr. Markus Schott and Jan Grossniklaus, the chapter discusses existing and upcoming pricing models, the evolving role of the Federal Office of Public Health and key legal considerations for the industry.